- Home
- BANF vs INDV Comparison
BANF vs INDV Comparison
Compare BANF & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BANF | INDV |
|---|---|---|
| Founded | 1984 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9B | 4.2B |
| IPO Year | 1994 | 2014 |
Fundamental Metrics
Financial Performance| Metric | BANF | INDV |
|---|---|---|
| Price | $106.83 | $35.53 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 4 |
| Target Price | ★ $124.00 | $49.00 |
| AVG Volume (30 Days) | 107.2K | ★ 1.2M |
| Earning Date | 10-20-2026 | 10-29-2026 |
| Dividend Yield | ★ 1.95% | N/A |
| EPS Growth | 10.40 | ★ 8100.00 |
| EPS | ★ 3.81 | 1.67 |
| Revenue | N/A | ★ $1,239,000,000.00 |
| Revenue This Year | $8.64 | $7.50 |
| Revenue Next Year | $7.04 | $5.07 |
| P/E Ratio | $28.06 | ★ $21.63 |
| Revenue Growth | N/A | ★ 4.29 |
| 52 Week Low | $101.48 | $23.14 |
| 52 Week High | $126.14 | $42.81 |
Technical Indicators
Market Signals| Indicator | BANF | INDV |
|---|---|---|
| Relative Strength Index (RSI) | 43.29 | 46.63 |
| Support Level | $106.28 | $33.45 |
| Resistance Level | $116.82 | $35.54 |
| Average True Range (ATR) | 2.06 | 0.96 |
| MACD | 0.01 | 0.10 |
| Stochastic Oscillator | 45.36 | 38.21 |
Price Performance
Historical ComparisonAbout BANF BancFirst Corporation
BancFirst Corp is engaged in providing banking services. The company's business unit includes BancFirst metropolitan banks, BancFirst community banks, Pegasus Bank, Worthington, other financial services and executive, operations and support. BancFirst metropolitan banks, BancFirst community banks, Pegasus and Worthington offer traditional banking products such as commercial and retail lending and a full line of deposit accounts. Its Other financial services are specialty product business units including guaranteed small business lending, residential mortgage lending, trust services, securities brokerage, electronic banking, and insurance.
About INDV Indivior PLC
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).